Square Peg Capital

Square Peg Capital is one of the most established venture firms in Australia, headquartered in Melbourne and operating across Australia, Israel, and Southeast Asia with a thesis focused on transformative internet economy startups and applied technology companies. Within healthcare the firm has concentrated on AI in healthcare, digital health, and health IT, with notable activity in AI-as-a-service platforms for hospital administration including investment in NexusMD.

The Square Peg thesis emphasizes companies with strong unit economics, defensible technology, and credible paths to international scale. The firm is not a deep biotech investor, preferring software, AI, and platform businesses where its team’s operating and venture expertise can translate into meaningful value-add. Within healthcare the focus on hospital administration AI, clinical workflow software, and digital health platforms reflects that posture; Square Peg gravitates toward enterprise software economics rather than therapeutic risk. AI is a recurring theme across recent activity, particularly for companies applying foundation models to industry-specific workflows.

Check sizes commonly fall in the five to twenty-five million dollar range, with the firm participating at seed, Series A, and Series B. The larger end of that range reflects Square Peg’s positioning as a meaningful lead at growth-oriented Series A and B rounds rather than a small-check seed firm. Geographic focus spans Australia, Israel, and Southeast Asia, with active investments in companies whose founders or operations span those markets. The Israel office is particularly active in deep tech and enterprise software, while the Australian and Southeast Asian activity tilts toward consumer and platform businesses.

The team includes senior partners with substantial venture and operating backgrounds, supported by an investment staff distributed across the firm’s offices. Decision-making moves through partnership process but the firm’s mid-size scale keeps that process reasonably efficient. Diligence is rigorous on financial and operational metrics rather than narrative, and the firm has built a reputation for being thoughtful but not slow.

For founders, Square Peg is most useful when the company has crossed the early product-market-fit threshold and is building toward international scale across the firm’s core geographies. Useful introductions tend to involve other regional and international institutional investors, enterprise customers across the Australia, Israel, and Southeast Asia network, and downstream growth and Series C investors. Post-investment engagement is steady; partners take board seats where appropriate and engage actively at major inflection points but generally let management teams run their companies. Founders looking for an investor that will participate in weekly operating cadence will find the relationship lighter than that, while those who want a thoughtful partner at strategic decisions will find the firm well-positioned. For AI in healthcare, digital health, and health IT companies building internationally from the Australia, Israel, or Southeast Asia ecosystems, Square Peg is among the most credible regional venture partners available.